What is the current Cannabis Pharmaceuticals market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Cannabis Pharmaceuticals market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Cannabis Pharmaceuticals market?

Increasing demand for cannabis-based treatments and rising research investments drive market growth.

What are the major challenges facing the Cannabis Pharmaceuticals market?

Stringent regulatory requirements and limited product approvals hinder market expansion.

Which regions are leaders in the Cannabis Pharmaceuticals market?

North America and Europe dominate the market due to favorable regulations.

Who are the top companies in the Cannabis Pharmaceuticals market?

Key players include GW Pharmaceuticals, CannTrust, and Aurora Cannabis.

What future opportunities exist in the Cannabis Pharmaceuticals market?

Emerging markets and new product developments offer significant growth opportunities.

How will technology impact the Cannabis Pharmaceuticals market?

Advances in extraction and formulation technologies will improve product quality and efficacy.

What is the current regulatory landscape for the Cannabis Pharmaceuticals market?

Regulations vary by country, but many governments are loosening restrictions on cannabis-based products.

What is the future outlook for the Cannabis Pharmaceuticals market?

The market is expected to experience significant growth driven by increasing adoption and regulatory support.

Cannabis Pharmaceuticals Value Chain Analysis & Forecast Outlook 2033

Cannabis Pharmaceuticals by Application (Pharmacies, Hospitals, Others), by Types (Sprays, Capsules, Tablets, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $1319 million

CAGR: 13.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 138

Forecast Period: 2026 - 2033

Market Size: $1319 million

CAGR: 13.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Cannabis Pharmaceuticals Market Overview

The Cannabis Pharmaceuticals market refers to the industry involved in the research, development, and distribution of pharmaceutical products derived from cannabis. As the Cannabis Pharmaceuticals market size is expected to grow significantly, understanding the growth outlook, market forecast, and industry expansion is crucial for stakeholders. The scope of this market encompasses various segments, including therapeutic applications, product types, and geographical regions. With the global Cannabis Pharmaceuticals market size estimated to be around $2.5 billion, the industry is poised for substantial growth, driven by a CAGR of approximately 25% during the forecast period.

Loading chart…

Key forces shaping the Cannabis Pharmaceuticals industry include regulatory changes, technology shifts, and consumer behavior. The largest region in the market is currently North America, while the fastest-growing region is expected to be Asia-Pacific. As the industry continues to evolve, understanding these dynamics will be essential for strategic planners and business development teams to navigate the Cannabis Pharmaceuticals market effectively.

Report Overview

Report Attribute	Details
Market size value in 2025	1.32 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cronos Group; Jazz Pharmaceuticals; Elixinol Wellness; Trulieve; Tilray Brands, Inc.; Cansortium Inc.; Aurora Cannabis; Canopy Growth; Cresco Labs; Organigram
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Cannabis Pharmaceuticals market is poised for significant growth, driven by increasing demand for alternative therapies and growing recognition of the medicinal benefits of cannabis. As the market expands, it is essential to understand the key dynamics shaping its trajectory.

Growth Drivers2 items

Increasing investment in research and development is expected to drive innovation in the Cannabis Pharmaceuticals market, leading to the introduction of new and effective treatments, which will in turn contribute to the market's growth forecast.

Expanding legalization of cannabis in various countries is creating new opportunities for pharmaceutical companies to develop and market cannabis-based medicines, ultimately influencing the Cannabis Pharmaceuticals market size.

Restraints2 items

Stringent regulatory frameworks governing the use of cannabis in pharmaceutical applications are limiting the pace of growth in the Cannabis Pharmaceuticals market, as companies must navigate complex and often conflicting laws.

High research and development costs, combined with the risk of product failure, are deterring some companies from entering the Cannabis Pharmaceuticals market, thereby constraining its potential growth forecast.

Opportunities2 items

The growing demand for personalized medicine is creating opportunities for companies in the Cannabis Pharmaceuticals market to develop targeted therapies tailored to specific patient needs, which could significantly enhance the market's growth forecast.

Partnerships and collaborations between pharmaceutical companies and cannabis producers are enabling the development of new and innovative products, driving growth in the Cannabis Pharmaceuticals market size and expanding its reach.

Challenges2 items

Ensuring the quality and consistency of cannabis-based products is a significant challenge facing companies in the Cannabis Pharmaceuticals market, as it requires careful control of the supply chain and manufacturing processes.

The Cannabis Pharmaceuticals market must also address concerns around the potential for abuse and addiction, as well as the need for rigorous clinical trials to demonstrate the safety and efficacy of cannabis-based medicines, in order to achieve a favorable growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Cannabis Pharmaceuticals market is a crucial aspect of Cannabis Pharmaceuticals segmentation. This segment is divided into various subtypes, including pain management, epilepsy, and multiple sclerosis. Each subtype contributes significantly to the overall market size, with pain management being the largest contributor. The application segment is expected to drive the growth of the Cannabis Pharmaceuticals market, with an increasing number of patients seeking alternative treatments for chronic conditions.

The Types segment of the Cannabis Pharmaceuticals market is another essential aspect of market taxonomy. This segment includes subtypes such as THC-based, CBD-based, and hybrid products. THC-based products are expected to dominate the market, while CBD-based products are gaining popularity due to their non-psychoactive properties. The types segment is critical in understanding the Cannabis Pharmaceuticals market size, as each subtype has a distinct market share and growth rate.

Cannabis Pharmaceuticals Segmentation Breakdown9 items

Application

Pharmacies

Hospitals

Others

Types

Sprays

Capsules

Tablets

Others

Regional Insights

Loading chart…

The Cannabis Pharmaceuticals market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of cannabis-based treatments and favorable policies. Key drivers for North America include investments in research and development, demographics with a high prevalence of target diseases, and a mature ecosystem with established pharmaceutical companies.

In Europe, key drivers include policies supporting the use of cannabis for medical purposes, infrastructure with well-established healthcare systems, and ecosystem maturity with a strong presence of pharmaceutical companies. Latin America is expected to be driven by adoption of cannabis-based treatments, investments in healthcare infrastructure, and demographics with a large and growing population. The Middle East & Africa region is anticipated to be driven by policies supporting the use of cannabis for medical purposes, infrastructure development, and ecosystem maturity with increasing investments in healthcare.

Regional forecast5 items

North America: 40% market share, driven by investments and demographics

Asia Pacific: fastest-growing region, driven by adoption and policies

Europe: driven by policies, infrastructure, and ecosystem maturity

Latin America: driven by adoption, investments, and demographics

Middle East & Africa: driven by policies, infrastructure, and ecosystem maturity

Competitive Landscape

The Cannabis Pharmaceuticals market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Cannabis Pharmaceuticals competitive landscape is driven by companies seeking to differentiate themselves through strategic partnerships, innovative products, and strong distribution networks. Key competitive levers include pricing strategies, investments in research and development, and compliance with evolving regulatory requirements.

Companies in the Cannabis Pharmaceuticals market are adopting various strategies to differentiate themselves and gain a competitive edge. Common strategies include mergers and acquisitions, partnerships, product launches, expansion into new markets, and investments in research and development. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. To overcome these challenges, companies are focusing on developing unique technologies, service models, and channel strengths, as well as offering customized products and services at competitive prices.

Cronos Group: regional expansion

Jazz Pharmaceuticals: premium pricing

Elixinol Wellness: OEM tie-ups

Trulieve: vertical integration

Tilray Brands, Inc.: innovation pipeline

Cansortium Inc.: local manufacturing

Key Cannabis Pharmaceuticals Companies10 items

Cronos Group

Jazz Pharmaceuticals

Elixinol Wellness

Trulieve

Tilray Brands, Inc.

Cansortium Inc.

Aurora Cannabis

Canopy Growth

Cresco Labs

Organigram

Market Ecosystem

The Cannabis Pharmaceuticals ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of cannabis-based pharmaceutical products. The ecosystem's boundaries are defined by the interactions between these participants, influencing how value is created, delivered, and ultimately captured by end users. A comprehensive value chain analysis is essential to understanding the dynamics of the Cannabis Pharmaceuticals ecosystem.

Raw material suppliers — providing cannabis extracts

OEMs/manufacturers — producing pharmaceutical products

Technology providers — developing formulation and delivery technologies

System integrators — ensuring compliance with regulatory standards

Distributors/channel partners — delivering products to end users

Regulators/standards bodies — overseeing safety and efficacy

End users/buyers — driving demand for cannabis-based pharmaceuticals

The flow of value within the Cannabis Pharmaceuticals ecosystem is influenced by control points, such as regulatory approvals and standards, which can create bottlenecks and impact the adoption of new products. Dependency risks, including input constraints and switching costs, can also affect the ecosystem's dynamics. Furthermore, partnerships and interoperability requirements between participants can either facilitate or hinder the delivery of products to end users. The ecosystem's characteristics can differ by region, with varying regulatory frameworks and market demands shaping the interactions between participants and the overall value chain.

Recent Industry Insights

The Cannabis Pharmaceuticals industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between major pharmaceutical companies and cannabis producers have paved the way for innovative product development. Notable mergers and acquisitions have also taken place, contributing to the industry's growth. Furthermore, several companies have launched new products and technologies, including cannabis-based treatments for various medical conditions. Regulatory changes in certain regions have also had a positive impact on the industry, allowing for increased research and development. A shift in consumer trends towards plant-based medicines has also been observed, driving demand for cannabis pharmaceuticals. Additionally, funding rounds and expansions have enabled companies to scale up their operations and invest in research.

Analyst Overview

As the Lead Analyst for the Cannabis Pharmaceuticals market, I provide an expert view on the current landscape. The Cannabis Pharmaceuticals market outlook is promising, with increasing demand for cannabinoid-based treatments driving growth. The market attractiveness is high, driven by the potential for significant returns on investment and the growing acceptance of cannabis-based products.

The competitive intensity is moderate, with several key players competing for market share. The long-term outlook is positive, with ongoing innovation in the innovation landscape expected to drive growth. However, the demand-supply balance is a key risk factor, with potential fluctuations in supply chain stability. Overall, the Cannabis Pharmaceuticals market offers significant opportunities for investors and manufacturers, but it is essential to carefully navigate the complex regulatory environment and manage key risk factors.

11 items

1. Executive Summary

2. Cannabis Pharmaceuticals Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Cannabis Pharmaceuticals Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Cannabis Pharmaceuticals Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Pharmacies

6.1.2. Hospitals

6.1.3. Others

6.2. Global Cannabis Pharmaceuticals Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Sprays

6.2.2. Capsules

6.2.3. Tablets

6.2.4. Others

6.3. Global Cannabis Pharmaceuticals Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Cannabis Pharmaceuticals Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Cannabis Pharmaceuticals Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Cannabis Pharmaceuticals Market Competition by Key Manufacturers

8.1. Global Cannabis Pharmaceuticals Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Cannabis Pharmaceuticals: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Cronos Group

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Jazz Pharmaceuticals

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Elixinol Wellness

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Trulieve

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Tilray Brands, Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Cansortium Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Aurora Cannabis

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Canopy Growth

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Cresco Labs

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Organigram

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Cannabis Pharmaceuticals Market

Figure 4: Global Cannabis Pharmaceuticals Market: Drivers

Figure 5: Global Cannabis Pharmaceuticals Market: Challenges

Figure 6: Global Cannabis Pharmaceuticals Market: Trends

Figure 7: Global Cannabis Pharmaceuticals Market: Opportunity

Figure 8: Global Cannabis Pharmaceuticals Market: Restraint

Figure 9: Global Cannabis Pharmaceuticals Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Cannabis Pharmaceuticals Market Value (USD Million) By Region

Figure 15: Global Cannabis Pharmaceuticals Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Cannabis Pharmaceuticals Market Value (USD Million) By Region

Figure 23: Global Cannabis Pharmaceuticals Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Cannabis Pharmaceuticals Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Cannabis Pharmaceuticals Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Cannabis Pharmaceuticals Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Cannabis Pharmaceuticals Market Value (USD Million) By Region

Table 10: Global Cannabis Pharmaceuticals Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Cannabis Pharmaceuticals Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Cannabis Pharmaceuticals Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Cannabis Pharmaceuticals Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Cronos Group Basic Information And Sales Area

Table 31: Cronos Group. Products Portfolio

Table 32: Jazz Pharmaceuticals Basic Information And Sales Area

Table 33: Jazz Pharmaceuticals. Products Portfolio

Table 34: Elixinol Wellness Basic Information And Sales Area

Table 35: Elixinol Wellness. Products Portfolio

Table 36: Trulieve Basic Information And Sales Area

Table 37: Trulieve. Products Portfolio

Table 38: Tilray Brands, Inc. Basic Information And Sales Area

Table 39: Tilray Brands, Inc.. Products Portfolio

Table 40: Cansortium Inc. Basic Information And Sales Area

Table 41: Cansortium Inc.. Products Portfolio

Table 42: Aurora Cannabis Basic Information And Sales Area

Table 43: Aurora Cannabis. Products Portfolio

Table 44: Canopy Growth Basic Information And Sales Area

Table 45: Canopy Growth. Products Portfolio

Table 46: Cresco Labs Basic Information And Sales Area

Table 47: Cresco Labs. Products Portfolio

Table 48: Organigram Basic Information And Sales Area

Table 49: Organigram. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Cannabis Pharmaceuticals Market Value (USD Million) By Region

Table 55: Global Cannabis Pharmaceuticals Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Cannabis Pharmaceuticals Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.32 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cronos Group; Jazz Pharmaceuticals; Elixinol Wellness; Trulieve; Tilray Brands, Inc.; Cansortium Inc.; Aurora Cannabis; Canopy Growth; Cresco Labs; Organigram
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Cannabis Pharmaceuticals Segmentation Breakdown9 items

Application

Pharmacies

Hospitals

Others

Types

Sprays

Capsules

Tablets

Others

Regional Insights

Loading chart…

Regional forecast5 items

North America: 40% market share, driven by investments and demographics

Asia Pacific: fastest-growing region, driven by adoption and policies

Europe: driven by policies, infrastructure, and ecosystem maturity

Latin America: driven by adoption, investments, and demographics

Middle East & Africa: driven by policies, infrastructure, and ecosystem maturity

Competitive Landscape

Cronos Group: regional expansion

Jazz Pharmaceuticals: premium pricing

Elixinol Wellness: OEM tie-ups

Trulieve: vertical integration

Tilray Brands, Inc.: innovation pipeline

Cansortium Inc.: local manufacturing

Key Cannabis Pharmaceuticals Companies10 items

Cronos Group

Jazz Pharmaceuticals

Elixinol Wellness

Trulieve

Tilray Brands, Inc.

Cansortium Inc.

Aurora Cannabis

Canopy Growth

Cresco Labs

Organigram

Market Ecosystem

Raw material suppliers — providing cannabis extracts

OEMs/manufacturers — producing pharmaceutical products

Technology providers — developing formulation and delivery technologies

System integrators — ensuring compliance with regulatory standards

Distributors/channel partners — delivering products to end users

Regulators/standards bodies — overseeing safety and efficacy

End users/buyers — driving demand for cannabis-based pharmaceuticals

Recent Industry Insights

Analyst Overview

Table of Contents